Cancer trials: Search results
Results: 13 items found.
Refine results
A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab Compared to Investigator’s Choice of Chemoimmunotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia Without del(17p) or TP53 Mutation
Trial short name: ACE-CLL-311
Cancer type: Blood Related
Cancer location: Leukemia
Disease stage: Early and Advanced Cancer
Trial phase: Phase 3
Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas
Trial short name: Astex 660
Cancer type: Blood Related
Cancer location: Lymphoma
Disease stage: Early and Advanced Cancer
Trial phase: Phase 2
A Randomized (1:1), Double-Blind, Multi-Centre, Placebo Controlled Study Evaluating Intensive Chemotherapy with or without Glasdegib (PF-04449913) or Azacitidine (AZA) with or without Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia
Trial short name: BRIGHT 1019
Cancer type: Blood Related
Cancer location: Leukemia
Disease stage: Early and Advanced Cancer
Trial phase: Phase 3
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications
Trial short name: CHIP
Cancer type: Blood Related
Cancer location: Lymphoma
Disease stage: Early Cancer
Trial phase: Other
Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients with Advanced Mycosis Fungoides and Sézary Syndrome: Advanced Stage PROCLIPI Project by the Cutaneous Lymphoma International Consortium (CLIC) Collaborative Alliance
Trial short name: CLIC Database
Cancer type: Blood Related
Cancer location: Other (Blood Related)
Disease stage: Advanced Cancer
Trial phase: Other
A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) versus Epoetin alfa for the Treatment of Anemia due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects who require Red Blood Cell Transfusions
Trial short name: Commands 002
Cancer type: Blood Related
Cancer location: Other (Blood Related)
Disease stage: Early Cancer
Trial phase: Phase 3
A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment
Trial short name: Geron MDS Imerge
Cancer type: Blood Related
Cancer location: Myelodysplastic Syndromes
Disease stage: Early Cancer
Trial phase: Phase 2, Phase 3
A Multi-Centre Phase III Study to Evaluate of Pre-Emptive Tenofovir on Prevention of Hepatitis B Virus Reactivation in HBsAg Negative/Anti-HBc Positive Individuals Undergoing Rituximab-Based Chemotherapy for Non-Hodgkin’s Lymphoma
Trial short name: HBV Ritux
Cancer type: Blood Related
Cancer location: Lymphoma
Disease stage: Other
Trial phase: Phase 3
Management of National MDS Clinical Database and Local Tissue Bank
Trial short name: MDS Database
Cancer type: Blood Related
Cancer location: Myelodysplastic Syndromes
Disease stage: Other
Trial phase: Other
Characterization of Drug-Resistant Tumor Re-Initiating Cellular Subpopulations and Pre-Clinical Validation of Novel Therapeutic Targets in Multiple Myeloma Using Patient-Derived Bone Marrow Samples
Trial short name: MM Bone Marrow
Cancer type: Blood Related
Cancer location: Multiple Myeloma
Disease stage: Other
Trial phase: Other
A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent
Trial short name: Onconova MDS
Cancer type: Blood Related
Cancer location: Myelodysplastic Syndromes
Disease stage: Other
Trial phase: Phase 3
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Trial short name: PNH Registry
Cancer type: Blood Related
Cancer location: Paroxysmal Nocturnal Hemoglobinuria
Disease stage: Other
Trial phase: Other
Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients with Philadelphia Negative Myeloproliferative Neoplasms
Trial short name: Portal HTN
Cancer type: Blood Related
Cancer location: Myeloproliferative Neoplasms
Disease stage: Other
Trial phase: Other
